Explore our resources by research/diagnostic specialty or content type
ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.
Are you curious about chemiluminescence ELISAs, but not exactly sure what they are, or how to use them? Our video A Comparison of Colorimetric and Chemiluminescence ELISAs discusses how similar these two types of assays are, and how they can enhance your lab testing.
Watch our video to:
Learn how chemiluminescence and colorimetric ELISAs measure biomarkers
Explore different types of ...
We know that the proper collection and handling of samples is vital for accurately measuring GLP-1.
ALPCO is here to help your lab reduce technical errors and improve assay results when running the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA.
Watch our video to learn how to properly collect and handle GLP-1 samples for more accurate results.
https://youtu.be/j6_YgA2NCO8
Video Trans...
We know that the proper collection and handling of samples is vital for eliminating analytical variability and improving accuracy when measuring active GLP-1 (7-36) amide.
ALPCO is here to help your lab reduce technical errors and improve assay results when running the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA.
Watch our video series to learn how DPP-4 complicates measuring GLP-1 acc...
Watch our video to learn more about the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and how you can now measure this incretin hormone with confidence.
https://www.youtube.com/watch?v=Chu3VhEEpt0&t=3s
The STELLUX® Chemi Active GLP-1 (7-36) amide ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25 µL sample volume...
In support of IBS Awareness Month, we created this short video to share some important facts about IBS and spread the word about this incurable, debilitating disorder.
Be sure to like and share our video to show your support of IBS Awareness Month!
https://youtu.be/6K_55Bg922s
Quick Facts About IBS
IBS was described as early as 1849 by Dr. Cumming in the London Medical Gazette.1
...
Nobel Prize winning British chemist Dr. Dorothy Hodgkin significantly contributed to unraveling the secrets of diabetes mellitus. She is considered a founder of X-ray crystallography, a technique used to discern the structures of organic biomolecules. Dorothy Hodgkin’s discovery of insulin's 3D structure paved the way for many scientific breakthroughs in diabetes research for years to follow. I...
Research over the past several decades examining adipokines and adipose tissue-liver crosstalk in energy metabolism has revealed that adipose tissue is a very important metabolically active endocrine organ1. White, brown, and beige adipose tissue generate and secrete adipokines, such as adiponectin and leptin, which facilitate adipose tissue-liver crosstalk and insulin sensitivity1.
https://...
Nonalcoholic fatty liver disease (NAFLD) / nonalcoholic steatohepatitis (NASH) is anticipated to become the next major health epidemic. NAFLD is a chronic disease ranging from fatty liver to NASH to advanced end stage liver failure. Currently, liver biopsy is the gold standard for clinical diagnosis of NASH and monitoring treatment response, but has several disadvantages. Therefore, alternative...
Presented by: Evelyn Zöhrer, PhD; Medical University of Graz
Bile acids act as emulsifiers and promote the absorption of lipids. In addition to the facilitation of digestion, bile acids are now being recognized as key players in the regulation of a myriad of metabolic processes. As such, the role of bile acids continues to be investigated in the context of health problems such as inflammator...
Drug-Induced Organ Injury
Toxicological side effects are a common obstacle in drug development pipelines and often manifest in site-specific damage to vital organs, including the liver, kidney and heart. Estimates of compound attrition from failure to meet safety endpoints are as high as 45% in preclinical models and 40% for Phase I clinical trials.1
Now more than ever, labs engaged in comp...